Rick Shinto, Managed Healthcare Guru

Rick Shinto, the CEO and President of InnovaCare Health. It is a leading company in the healthcare sector, providing managed health care services. Its programs seek to enhance and deliver high quality and affordable services to the masses.

 

It runs the Medicare and Medicaid programs. The company serves a large number of people in various locations including Puerto Rico. The company’s primary objective is to help people achieve overall wellness physically, mentally and emotionally.

 

Preference of InnovaCare Health is high thanks to their high-quality pocket-friendly services. Despite being in the market for a short while now, the company has grown immensely. Good leadership has played an integral part in the success of InnovaCare.

 

Rick Shinto, the CEO, is a State University medical graduate. He also did his MBA at Redlands University. He has exemplary leadership skills from his experience. For over two decades now, Dr. Rick has been in the managed medical services field.

 

Before joining InnovaCare, Rick Shinto worked with numerous successful managed health care providing firms. He also held top managerial positions in some of them such as Aveta Inc and NAMM California. From these positions, he gathered vast experience that has made him the leader he is today. He also writes journals about the healthcare industry.

 

At InnovaCare, Rick Shinto does not work alone. His work complements three other professionals who joined him recently. Of the three, Penelope Kokkinides is unmatched in her work. She is the chief administrative officer.

 

Dr. Shinto is a force to be reckoned with. He has brought changes to the InnovaCare and has seen the company rise to its current position. He envisions the company venturing into new markets. That will enable improvement of service provided to patients.

 

Under Shinto’s leadership, InnovaCare has made doctor visits more affordable hence frequent. That has seen their clientele proliferate. The company has also ventured into Puerto Rico, improving availability and affordability of medical care. The company has also helped health care providers to integrate their services with technology. That aims at making the process more efficient.

 

Richard Shinto is an award winner of the Ernst & Young Entrepreneur of the Year Award. He scooped this award as a result of his commitment and dedication as an entrepreneur in providing excellent services.

 

The parameters used are innovativeness, financial performance and improving quality of life of the community. Shinto’s experience, business expertise and his honesty in service rendering have brought prosperity to InnovaCare Health.

 

Mikhail Blagosklonny life and career as a research scientist.

For many years now scientist from all over the world have been trying to decipher the aging process in a human being and how it can be stopped or made to slow down. Many scientists have therefore rededicated their study and time to the new science of aging, and as a result, significant advancements have been made. One such scientist who for many years now has been carrying out endless experiments on new ways of solving or indeed stopping the aging process is Mikhail Blagosklonny.

Mikhail Blagosklonny is a renowned scientist who is well known for his research work when it comes to both the study of cancer and the aging process in human beings. Aside from that, Blagosklonny doubles up as a professor and a philanthropist who always wants to help those that are less fortunate in the society. It is this nature of caring for others that drive Michael to strive to find a cure or come up with new and improved treatment regiments for cancer at a lower price affordable to everyone and more information click here.

Blagosklonny’s educational background is one that exudes exceptional brilliance having attended some of the top institutions attaining a medical degree and later on pursuing his Ph. D. in the field of cardiology and experimental medicine. In the year 2009, he became a senior scientist at a research center called Ordway Research Institute but begun his professorship back in 2002 at New York Medical College and resume him.

In his quest as a researcher, Mikhail Blagoskonny is profoundly interested in the interrelation between cancer and aging in people. Research conducted previously revealed that cancer tends to occur in older people who are, mostly above a certain age. His research projects have significantly contributed a significant amount of knowledge to the field of oncology.

The research carried out by Blagoskonny about finding a cure for cancer and aging process majorly relies on rapamycin. In his quest, the observation made earlier associating the development of cancer and aging was solvable by being able to administer rapamycin safely. Rapamycin itself is an agent that slows down aging and in turn reducing the rate of people contracting cancer. This school of thought indeed had grounds of support from numerous studies that had been done on rats showing that this is indeed practical.

The ability of rapamycin delaying the aging process and cancer development itself can subsequently be reduced in people who use rapamycin. However, there is catch to the effectiveness of rapamycin when the ultimate goal is limiting the development of cancer. This is because for rapamycin to function effectively, its administration should occur before cancer develops in a person. Its administration after cancer has started developing would be futile since its effectiveness would be blunted and learn more about Mikhail.

In its mode of action, rapamycin acts by suppressing geroconversion which in actual sense is the cellular basis for the aging process in all organisms. Therefore, its administration responds by countering specific aging agents in all organisms, for example, plasma sodium, the concentration of chloride and calcium.